Stimart Tryn's most recent trade in AbCellera Biologics Inc was a trade of 832,033 Share option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 832,033 | 4,106,747 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Stimart Tryn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2024 | 616,333 | 3,274,714 | - | - | Share option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 346,901 | 2,658,381 | - | - | Share Options (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 270,680 | 2,311,480 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 09 Jun 2021 | 1,000,000 | 250 | - | 25.5 | 25,500,000 | Common Shares |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 750,000 | 1,250,000 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.32 per share. | 07 Jun 2021 | 750,000 | 750,250 | - | 0.3 | 240,000 | Common Shares |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 07 Jun 2021 | 250,000 | 1,000,250 | - | 2.3 | 575,000 | Common Shares |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 250,000 | 600,000 | - | - | Share Option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 850,000 | 850,000 | - | - | Stock Option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 190,800 | 190,800 | - | - | Stock Option (right to buy) | |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 15 Dec 2020 | 250 | 250 | - | 20 | 5,000 | Common Shares |
| AbCellera Biologics Inc | Tryn Stimart | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 15 Dec 2020 | 250 | 250 | - | 20 | 5,000 | Common Shares |